APA

García M., Moreno R., Gil-Martin M., Cascallò M., de Olza M. O., Cuadra C., Piulats J. M., Navarro V., Domenech M., Alemany R. & Salazar R. (20200312). A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. : Human gene therapy.

Chicago

García Margarita, Moreno Rafael, Gil-Martin Marta, Cascallò Manel, de Olza Maria Ochoa, Cuadra Carmen, Piulats Josep Maria, Navarro Valentin, Domenech Marta, Alemany Ramon and Salazar Ramon. 20200312. A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. : Human gene therapy.

Harvard

García M., Moreno R., Gil-Martin M., Cascallò M., de Olza M. O., Cuadra C., Piulats J. M., Navarro V., Domenech M., Alemany R. and Salazar R. (20200312). A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. : Human gene therapy.

MLA

García Margarita, Moreno Rafael, Gil-Martin Marta, Cascallò Manel, de Olza Maria Ochoa, Cuadra Carmen, Piulats Josep Maria, Navarro Valentin, Domenech Marta, Alemany Ramon and Salazar Ramon. A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. : Human gene therapy. 20200312.